يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"DNA Modification Methylases/genetics"', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 1

    المصدر: Cell death & disease, vol. 13, no. 12, pp. 1037

    وصف الملف: application/pdf

  2. 2
  3. 3

    المساهمون: Neurology, CCA - Cancer biology and immunology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Acta Neuropathologica, 135(4), 601-615
    Acta Neuropathologica, 135, 4, pp. 601-615
    Acta Neuropathologica, 135(4), 601-615. Springer Verlag
    Acta Neuropathologica, 135, 601-615
    Acta Neuropathologica, 135(4), 601-615. SPRINGER
    Bady, P, Kurscheid, S, Delorenzi, M, Gorlia, T, van den Bent, M J, Hoang-Xuan, K, Vauléon, É, Gijtenbeek, A, Enting, R, Thiessen, B, Chinot, O, Dhermain, F, Brandes, A A, Reijneveld, J C, Marosi, C, Taphoorn, M J B, Wick, W, von Deimling, A, French, P, Stupp, R, Baumert, B G & Hegi, M E 2018, ' The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033 ', Acta Neuropathologica, vol. 135, no. 4, pp. 601-615 . https://doi.org/10.1007/s00401-018-1810-6
    Acta Neuropathologica, 135(4), 601-615. Springer, Cham
    Acta neuropathologica, vol. 135, no. 4, pp. 601-615
    Acta Neuropathologica, 135(4), 601-615. Springer-Verlag

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Epigenesis, Genetic, MISMATCH REPAIR, 0302 clinical medicine, Promoter Regions, Genetic, DNA Modification Methylases, DNA methylation, Brain Neoplasms, METHYLATION, TEMOZOLOMIDE, Glioma, Methylation, TUMORS, Isocitrate Dehydrogenase, Progression-Free Survival, 3. Good health, Treatment Outcome, Isocitrate dehydrogenase, CpG site, 030220 oncology & carcinogenesis, Female, DNA mismatch repair, Adult, Antineoplastic Agents, Alkylating/therapeutic use, Brain Neoplasms/genetics, Brain Neoplasms/pathology, Brain Neoplasms/therapy, CpG Islands, DNA, DNA Methylation/drug effects, DNA Methylation/radiation effects, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Discoidin Domain Receptors/genetics, Glioma/genetics, Glioma/pathology, Glioma/therapy, Humans, Isocitrate Dehydrogenase/genetics, Neoplasm Grading, Temozolomide/therapeutic use, Tumor Suppressor Proteins/genetics, DDR genes, Low-grade glioma, MGMT-STP27, Randomized trial, TMZ, SENSITIVITY, MGMT, medicine.drug, RADIOTHERAPY, EXPRESSION, medicine.medical_specialty, GLIOBLASTOMA, Other Research Donders Center for Medical Neuroscience [Radboudumc 0], Pathology and Forensic Medicine, 03 medical and health sciences, Cellular and Molecular Neuroscience, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, Progression-free survival, Antineoplastic Agents, Alkylating, Discoidin Domain Receptors, neoplasms, Temozolomide, business.industry, Tumor Suppressor Proteins, medicine.disease, DNA Repair Enzymes, 030104 developmental biology, CELLS, Neurology (clinical), business

    وصف الملف: application/pdf

  4. 4

    المساهمون: University of Zurich, Hegi, Monika E

    المصدر: Clin Cancer Res
    Clinical cancer research, vol. 25, no. 6, pp. 1809-1816

    وصف الملف: Hegi_MGMT.pdf - application/pdf; application/pdf

  5. 5

    المساهمون: Neurology, University of Zurich, Wick, Wolfgang

    المصدر: Clinical Cancer Research, 22(19), 4797-4806. American Association for Cancer Research Inc.
    Clinical Cancer Research, 22(19), 4797-4806
    Clinical Cancer Research
    Clinical cancer research, vol. 22, no. 19, pp. 4797-4806

    وصف الملف: 1078-0432.CCR-15-3153.full.pdf - application/pdf; application/pdf

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    المساهمون: Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Centre Scientifique et Technique du Bâtiment (CSTB), Unité d'épidémiologie, biostatistique et registre des cancers [Poitou-Charentes], Institut Charles Gerhardt Montpellier - Institut de Chimie Moléculaire et des Matériaux de Montpellier (ICGM ICMMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut de Chimie du CNRS (INC), Photomécanique et analyse expérimentale en Mécanique des solides (PEM), Département Génie Mécanique et Systèmes Complexes (GMSC), Institut Pprime (PPRIME), Université de Poitiers-ENSMA-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers-ENSMA-Centre National de la Recherche Scientifique (CNRS)-Institut Pprime (PPRIME), Université de Poitiers-ENSMA-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers-ENSMA-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Mitochondrie : Régulations et Pathologie, Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Cellules souches leucémiques et thérapeuthiques, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers), Univ Angers, Okina, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), INSERM CIC 0802 (INSERM - CHU de Poitiers), Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: British Journal of Cancer
    British Journal of Cancer, Cancer Research UK, 2008, 98 (11), pp.1830-8. ⟨10.1038/sj.bjc.6604378⟩

    وصف الملف: application/pdf